Literature DB >> 25783883

Selective disruption of the AKAP signaling complexes.

Eileen J Kennedy1, John D Scott.   

Abstract

Synthesis of the second messenger cAMP activates a variety of signaling pathways critical for all facets of intracellular regulation. Protein kinase A (PKA) is the major cAMP-responsive effector. Where and when this enzyme is activated has profound implications on the cellular role of PKA. A-Kinase Anchoring Proteins (AKAPs) play a critical role in this process by orchestrating spatial and temporal aspects of PKA action. A popular means of evaluating the impact of these anchored signaling events is to biochemically interfere with the PKA-AKAP interface. Hence, peptide disruptors of PKA anchoring are valuable tools in the investigation of local PKA action. This article outlines the development of PKA isoform-selective disruptor peptides, documents the optimization of cell-soluble peptide derivatives, and introduces alternative cell-based approaches that interrogate other aspects of the PKA-AKAP interface.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783883      PMCID: PMC4722817          DOI: 10.1007/978-1-4939-2537-7_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  68 in total

Review 1.  Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function.

Authors:  George D Dalton; William L Dewey
Journal:  Neuropeptides       Date:  2006-01-26       Impact factor: 3.286

2.  Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor.

Authors:  Cathrine Rein Carlson; Birgitte Lygren; Torunn Berge; Naoto Hoshi; Wei Wong; Kjetil Taskén; John D Scott
Journal:  J Biol Chem       Date:  2006-05-25       Impact factor: 5.157

3.  Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes.

Authors:  Andrea L Bauman; Joseph Soughayer; Bao T Nguyen; Debbie Willoughby; Graeme K Carnegie; Wei Wong; Naoto Hoshi; Lorene K Langeberg; Dermot M F Cooper; Carmen W Dessauer; John D Scott
Journal:  Mol Cell       Date:  2006-09-15       Impact factor: 17.970

4.  High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides.

Authors:  Christian Hundsrucker; Gerd Krause; Michael Beyermann; Anke Prinz; Bastian Zimmermann; Oliver Diekmann; Dorothea Lorenz; Eduard Stefan; Pavel Nedvetsky; Margitta Dathe; Frank Christian; Theresa McSorley; Eberhard Krause; George McConnachie; Friedrich W Herberg; John D Scott; Walter Rosenthal; Enno Klussmann
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

5.  Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.

Authors:  C W Dessauer; T T Scully; A G Gilman
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

6.  EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.

Authors:  L Zeng; S An; E J Goetzl
Journal:  J Pharmacol Exp Ther       Date:  1998-09       Impact factor: 4.030

Review 7.  Overview of PDEs and their regulation.

Authors:  Kenji Omori; Jun Kotera
Journal:  Circ Res       Date:  2007-02-16       Impact factor: 17.367

Review 8.  Prostaglandin E receptors.

Authors:  Yukihiko Sugimoto; Shuh Narumiya
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

9.  A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase.

Authors:  Francis S Kinderman; Choel Kim; Sventja von Daake; Yuliang Ma; Bao Q Pham; Glen Spraggon; Nguyen-Huu Xuong; Patricia A Jennings; Susan S Taylor
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

10.  Molecular basis of AKAP specificity for PKA regulatory subunits.

Authors:  Matthew G Gold; Birgitte Lygren; Pawel Dokurno; Naoto Hoshi; George McConnachie; Kjetil Taskén; Cathrine R Carlson; John D Scott; David Barford
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

View more
  14 in total

1.  HK2 Recruitment to Phospho-BAD Prevents Its Degradation, Promoting Warburg Glycolysis by Theileria-Transformed Leukocytes.

Authors:  Malak Haidar; Anne Lombès; Frédéric Bouillaud; Eileen J Kennedy; Gordon Langsley
Journal:  ACS Infect Dis       Date:  2017-01-24       Impact factor: 5.084

2.  Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Authors:  Thomas M Moon; Nathan R Tykocki; Jessica L Sheehe; Brent W Osborne; Werner Tegge; Joseph E Brayden; Wolfgang R Dostmann
Journal:  Chem Biol       Date:  2015-12-17

3.  Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide.

Authors:  Briana R Flaherty; Tienhuei G Ho; Sven H Schmidt; Friedrich W Herberg; David S Peterson; Eileen J Kennedy
Journal:  ACS Infect Dis       Date:  2019-02-18       Impact factor: 5.084

Review 4.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 5.  Cell penetrating peptides to dissect host-pathogen protein-protein interactions in Theileria-transformed leukocytes.

Authors:  Malak Haidar; Perle Latré de Laté; Eileen J Kennedy; Gordon Langsley
Journal:  Bioorg Med Chem       Date:  2017-09-07       Impact factor: 3.641

Review 6.  AKAP Signaling Islands: Venues for Precision Pharmacology.

Authors:  Mitchell H Omar; John D Scott
Journal:  Trends Pharmacol Sci       Date:  2020-10-17       Impact factor: 14.819

Review 7.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

8.  Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2.

Authors:  N George Bendzunas; Sabrina Dörfler; Karolin Autenrieth; Daniela Bertinetti; Erik M F Machal; Eileen J Kennedy; Friedrich W Herberg
Journal:  Bioorg Med Chem       Date:  2018-02-12       Impact factor: 3.641

9.  Defining A-Kinase Anchoring Protein (AKAP) Specificity for the Protein Kinase A Subunit RI (PKA-RI).

Authors:  Karolin Autenrieth; N George Bendzunas; Daniela Bertinetti; Friedrich W Herberg; Eileen J Kennedy
Journal:  Chembiochem       Date:  2015-12-17       Impact factor: 3.164

Review 10.  cAMP-Dependent Signaling Pathways as Potential Targets for Inhibition of Plasmodium falciparum Blood Stages.

Authors:  Edwin Lasonder; Kunal More; Shailja Singh; Malak Haidar; Daniela Bertinetti; Eileen J Kennedy; Friedrich W Herberg; Anthony A Holder; Gordon Langsley; Chetan E Chitnis
Journal:  Front Microbiol       Date:  2021-05-24       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.